Stanley CA, et al. Advances in diagnosis and treatment of hyperinsulinism in infants and children. J Clin Endocrinol Metab. 2002;87:4857–9.

Article  CAS  PubMed  Google Scholar 

De Leon DD, Stanley CA, et al. Mechanism of disease: advances in diagnosis and treatment of hyperinsulinism in neonates. Nat Clin Pract Endocrinol Metab. 2007;3:57–8.

Article  PubMed  Google Scholar 

Yamada Y, Kitayama K, Oyachi M, Higuchi S, Kawakita R, Kanamori Y, Yorifuji T, et al. Nationwide survey of endogenous hyperinsulinemic hypoglycemia in Japan (2017–2018): congenital hyperinsulinism, insulinoma, non-insulinoma pancreatogenous hypoglycemia syndrome and insulin autoimmune syndrome (Hirata’s disease). J Diabetes Investig. 2020;11:554–63.

Article  PubMed  Google Scholar 

Kawakita R, Sugimine H, Nagai S, et al. Clinical characteristics of congenital hyperinsulinemic hypoglycemia in infant: a nationwide epidemiological survey in Japan. J Jpn Pediatr Soc. 2011;115:563–9.

Google Scholar 

Yorifuji T, Horikawa R, Hasegawa T, et al. Clinical practice guidelines for congenital hyperinsulinism. Clin Pediatr Endcrinol. 2017;26:127–52.

Article  Google Scholar 

Westers A, Lerch C, Kummer S, Marquard J, Salgin B, Mayatepek E, Meissner T, et al. Long-term medical treatment in congenital hyperinsulinism: a descriptive analysis in a large cohort of patients from different clinical centers. Orphanet J Rare Dis. 2015;10:150.

Glaser B, Hirsh HJ, Landau H. Persistent hyperinsulinemic hypoglycemia of infancy: long-term octreotide treatment without pancreatomy. J Pediatr. 1993;123:644–50.

Thornton PS, Alter CA, Katz LE, Baker L, Stanley CA. Short-and long-term use of octreotide in the treatment of congenital hyperinsulinism. J Pediatr. 1993;123:637–43.

Article  CAS  PubMed  Google Scholar 

Arya VB, Senniappan S, Demirbilek H, Alam S, Flanagan SE, Ellard S, Hussain K. Pancreatic endocrine and exocrine function in children following near-total pancreatectomy for diffuse congenital hyperinsulinism. PLoS ONE. 2014;9:e98054.

Article  PubMed  PubMed Central  Google Scholar 

Beltrand J, Caquard M, Arnoux JB, Laboede K, Velho G, Verkarre V, Rahier J, Brunelle F, Nohoul-Fékété C, Saudubray JM, Robert JJ, de Lonlay P. Glucose metabolism in 105 children and adolescent after pancreatectomy for congenital hyperinsulinism. Diabetes Care. 2012;35:198–203.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Barthlen W, Mohnike W, Mohnike K. Techniques in pediatric surgery: congenital hyperinsulinism. Horm Res Pediatr. 2011;75:304–10.

Article  CAS  Google Scholar 

Blomberg BA, Moghbel MC, Stanley CA, Alavi A. The value of radiologic interventions and (18)F-DOPA PET in diagnosing and localizing focal congenital hyperinsulinism: systematic review and meta-analysis. Mol Imaging Biol. 2013;15:97–105.

Article  PubMed  Google Scholar 

Mohnike K, Blankenstein O, Cheistesen HT, De Lonlay J, Hussan K, Koopmans KP, Minn H, Mohnike W, Mutair A, Otonkoski T, Rahier J, Ribero M, Schoenle E, Fékété CN. Proposal for standardized protocol for 18F-DOPA-PET(PET/CT) in congenital hyperinsulinism. Horm Res. 2006;66:40–2.

CAS  PubMed  Google Scholar 

Banerjee I, Skae M, Flanagan SE, Rigby L, Patel L, Didi M, Blair J, Ehtisham S, Ellard S, Cosgrove KE, Dunne MJ, Clayton PE. The contribution of rapid KATP channel gene mutation analysis to the clinical management of children with congenital hyperinsulinism. Eur J Endocrinol. 2011;164:733–40.

Article  CAS  PubMed  Google Scholar 

Banerjee I, Avatapalle B, Padidela R, Stevens A, Cosgrove KE, Clayton PE, Dunne MJ. Integrating genetic and imaging investigation into the clinical management of congenital hyperinsulinism. Clin Endocrinol. 2013;78:803–13.

Article  CAS  Google Scholar 

Yidizdas D, Erdem S, Kucukosmanoglu O, Yilmaz M, Yuksel B. Pulmonary hypertention, heart failure and neutropenia due to diazoxide therapy. Adv Ther. 2008;25:515–9.

Article  Google Scholar 

Demirel F, Unal S, Cetin II, Esen I, Arasli A. Pulmonary hypertention and reporting of the ductus arteriosus in an infant treated with diazoxide. J Pediatr Endcrinol Metab. 2011;24:603–5.

Google Scholar 

Ponmani C, Gannon H, Hussain K, Sennniappan S. Paradoxical hypoglycemia associated with diazoxide therapy for hyperinsulinemic hypoglycaemia. Horm Res Paediatr. 2013;80:120–33.

Article  Google Scholar 

Gohda Y, Oka S, Matsunada T, Watanabe S, Yoshiura K, Kondoh T, Matsumoto T. Neonatal case of novel KMT2D mutation in Kabuki syndrome with severe hypoglycemia. Pediatr Int. 2015;57:726–8.

Article  CAS  PubMed  Google Scholar 

Fukutomi M, Shimodera M, Maeda Y, Iwakura M, Hara M, et al. Safety and effectiveness, including intelligence prognosis, of diazoxide in pediatric patients with hyperinsulinemic hypoglycemia: special survey in Japan (long-term, all case study). Clin Pediatr Endcrinol. 2018;27(3):131–43.

Article  Google Scholar 

Ishikawa N, et al. Clinical analysis of long-term treatment with diazoxide for hyperinsulinemic hypoglycemia. Clin Endocrinol. 1995;43(9):73–89. (In Japanese).

Tosur M, Viau-Colimdres J, Astudillo M, Jose Redondo M, Lyons SK, et al. Medication-induced hyperglycemia: pediatric perspective. BMJ Open Res Care. 2020;8(1):e000801.

Thewjitcharoen Y, et al. Diabetes mellitus and insulin resistance associated with Kabuki syndrome—a case report and literature review. Clin Case Rep. 2022;10:e05736.

Article  PubMed  PubMed Central  Google Scholar